Results 111 to 120 of about 9,133 (278)
Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block [PDF]
, 2005 Marissa Shields +5 more
openalex +1 more source
Sugammadex in pediatric patients
Anesthesia and Pain Medicine, 2022 Jae Moon Choi, Hong Seuk Yang
openaire +3 more sources
Neostigmine versus Sugammadex and the Relationship to Reintubation Rates in the PACU [PDF]
, 2020 Background Findings Discussion Reintubation in the post-anesthesia care unit (PACU) is a complication that may be related to residual neuromuscular blockade. Neostigmine and sugammadex have different pharmacokinetics that effect speed and completeness of
Daratha, Kenn B +2 more
core +1 more source
Anaphylaxis to Sugammadex [PDF]
Anaesthesia and Intensive Care, 2014 L. Savic +2 more
openaire +3 more sources
Solid State Form of Sugammadex Sodium and Process for Preparation Thereof [PDF]
, 2020 Provided herein is a solid state form of Sugammadex sodium and process for its ...
, Srinivasan Thirumalai Rajan
core +1 more source
Annals of Cardiac Anaesthesia, 2017 Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller +2 more
doaj +1 more source
Sugammadex and laryngospasm [PDF]
Anaesthesia, 2017 S. Greenaway, S. Shah, M. Dancey
openaire +3 more sources
Emerging considerations in the reversal of neuromuscular blockade and residual block [PDF]
, 2008 Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future.
CHRISTOPHER J. JANKOWSKI +2 more
core +2 more sources
Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium [PDF]
, 2019 Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockade. The recommended dose is 2 mg/kg.
Bougouma, Cheik Tidiane Hafid Wind-Pouiré +1 more
core +1 more source
BMC Anesthesiology, 2018 Background Previous studies have shown that sugammadex resulted in the prolongation of prothrombin time and activated partial thromboplastin time. In this study, we aimed to investigate the in vitro effects of exogenous sugammadex on the coagulation ...
Il Ok Lee +5 more
doaj +1 more source